Healthcare barriers impact cancer care and disease prevention in Ghana and South Africa

Healthcare challenges in Ghana and South Africa highlight significant barriers to effective disease management and prevention. In Ghana, research indicates that while cancer awareness is vital, patients face systemic hurdles in transitioning from symptom recognition to treatment. A study in the Oti and Volta regions found that 21.1% of women referred for biopsies did not undergo the procedure, and 64% of those with confirmed malignancy successfully started treatment, while 36% did not. Barriers included costs, transport, and confusing referral pathways.

In South Africa, studies address cervical cancer and the potential introduction of a gonorrhoea vaccine. In Soweto, healthcare providers identified inadequate training, staff rotations, and resource shortages—such as lack of supplies and lab access—as primary obstacles to early cervical cancer detection. Patients also demonstrated limited awareness and a tendency toward self-medication or traditional practitioners.

Regarding gonorrhoea, experts suggest that while a vaccine could mitigate antimicrobial resistance and infection rates, its successful introduction in South Africa depends on addressing vaccine hesitancy, social stigma, and healthcare infrastructure. Integrating such a vaccine into existing immunization programs is recommended to improve logistical feasibility.